首页> 美国卫生研究院文献>Nature Communications >Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis
【2h】

Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis

机译:miR-122在人和小鼠中靶向TGFβ途径的差异影响肝癌转移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Downregulation of a predominantly hepatocyte-specific miR-122 is associated with human liver cancer metastasis, whereas miR-122-deficient mice display normal liver function. Here we show a functional conservation of miR-122 in the TGFβ pathway: miR-122 target site is present in the mouse but not human TGFβR1, whereas a noncanonical target site is present in the TGFβ1 5′UTR in humans and other primates. Experimental switch of the miR-122 target between the receptor TGFβR1 and the ligand TGFβ1 changes the metastatic properties of mouse and human liver cancer cells. High expression of TGFβ1 in human primary liver tumours is associated with poor survival. We identify over 50 other miRNAs orthogonally targeting ligand/receptor pairs in humans and mice, suggesting that these are evolutionarily common events. These results reveal an evolutionary mechanism for miRNA-mediated gene regulation underlying species-specific physiological or pathological phenotype and provide a potentially valuable strategy for treating liver-associated diseases.
机译:主要是肝细胞特异性miR-122的下调与人类肝癌转移有关,而miR-122缺陷的小鼠显示出正常的肝功能。在这里,我们显示了miR-122在TGFβ途径中的功能保守性:miR-122靶位点存在于小鼠中,而人类TGFβR1不存在,而人类和其他灵长类动物的TGFβ15'UTR中存在非经典靶位。 miR-122靶标在受体TGFβR1和配体TGFβ1之间的实验转换改变了小鼠和人类肝癌细胞的转移特性。 TGFβ1在人原发性肝肿瘤中的高表达与生存不良有关。我们确定了人类和小鼠中正交靶向配体/受体对的50多个其他miRNA,表明这些是进化上的常见事件。这些结果揭示了miRNA介导的基因调控的进化机制,该机制调控着物种特异性的生理或病理表型,并为治疗肝脏相关疾病提供了潜在的有价值的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号